Credit Suisse’s Acceleron Pharma XLRN Stock Holding History

Credit Suisse’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-8,700	Closed	-$357K	–	4320
2019 Q2	$357K	Buy	+8,700	New	+$360K	﹤0.01%	3595
2019 Q1	–	Sell	-8,300	Closed	-$361K	–	4203
2018 Q4	$361K	Buy	+8,300	New	+$415K	﹤0.01%	3427

Credit Suisse's XLRN Position: Q4 2021 in Review

Credit Suisse sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 93,147 shares — an estimated $16M sold.

Credit Suisse first reported a position in XLRN in Q4 2013 and held it in 32 quarters. The position peaked at $16M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Credit Suisse reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Credit Suisse sold 93,147 Acceleron Pharma shares in Q4 2021, an estimated $16M.
Credit Suisse first reported a position in Acceleron Pharma in Q4 2013 and held it in 32 quarters.
Credit Suisse's Acceleron Pharma position peaked at $16M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Credit Suisse's 13F filing for Q4 2021, filed 14 Feb 2022.